Selected research
Industry Growth & Trends
Global Absorbable Hemostatic Agents Industry Growth and Trends Forecast to 2032
Market perspective
The global Absorbable Hemostatic Agents market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Absorbable Hemostatic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Absorbable Hemostatic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Absorbable Hemostatic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Absorbable Hemostatic Agents include BD, Biotemed, Cura Medical, Curasan AG, Foryou Medical, GELITA MEDICAL, Meril Life Sciences, Saikesaisi Holdings Group and Zhonghui Shengxi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Absorbable Hemostatic Agents market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Absorbable Hemostatic Agents market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Absorbable Hemostatic Agents market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Absorbable Hemostatic Agents.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Absorbable Hemostatic Agents market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Absorbable Hemostatic Agents Market by Company
BD
Biotemed
Cura Medical
Curasan AG
Foryou Medical
GELITA MEDICAL
Meril Life Sciences
Saikesaisi Holdings Group
Zhonghui Shengxi
Baxter
Beijing Taikesiman
B.Braun
Beijing Datsing Bio-tech
Guizhou Jin Jiu Biotech
Johnson & Johnson
Absorbable Hemostatic Agents Segment by Type
Gauze
Gelatin Sponge
Powder
Other
Absorbable Hemostatic Agents Segment by Application
Hospital
Clinics
Others
Absorbable Hemostatic Agents Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Absorbable Hemostatic Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Absorbable Hemostatic Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Absorbable Hemostatic Agents.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Absorbable Hemostatic Agents manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Absorbable Hemostatic Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Gauze
- Gelatin Sponge
- Powder
- Other
Applications
- Hospital
- Clinics
- Others
Companies covered
- BD
- Biotemed
- Cura Medical
- Curasan AG
- Foryou Medical
- GELITA MEDICAL
- Meril Life Sciences
- Saikesaisi Holdings Group
- Zhonghui Shengxi
- Baxter
- Beijing Taikesiman
- B.Braun
- Beijing Datsing Bio-tech
- Guizhou Jin Jiu Biotech
- Johnson & Johnson
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Absorbable Hemostatic Agents Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Absorbable Hemostatic Agents Sales Estimates and Forecasts (2021-2032)
- 1.3 Absorbable Hemostatic Agents Market by Type
- 1.3.1 Gauze
- 1.3.2 Gelatin Sponge
- 1.3.3 Powder
- 1.3.4 Other
- 1.4 Global Absorbable Hemostatic Agents Market Size by Type
- 1.4.1 Global Absorbable Hemostatic Agents Market Size Overview by Type (2021-2032)
- 1.4.2 Global Absorbable Hemostatic Agents Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Absorbable Hemostatic Agents Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Absorbable Hemostatic Agents Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Absorbable Hemostatic Agents Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Absorbable Hemostatic Agents Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Absorbable Hemostatic Agents Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Absorbable Hemostatic Agents Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Absorbable Hemostatic Agents Industry Trends
- 2.2 Absorbable Hemostatic Agents Industry Drivers
- 2.3 Absorbable Hemostatic Agents Industry Opportunities and Challenges
- 2.4 Absorbable Hemostatic Agents Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Absorbable Hemostatic Agents Revenue (2021-2026)
- 3.2 Global Top Players by Absorbable Hemostatic Agents Sales (2021-2026)
- 3.3 Global Top Players by Absorbable Hemostatic Agents Price (2021-2026)
- 3.4 Global Absorbable Hemostatic Agents Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Absorbable Hemostatic Agents Major Company Production Sites & Headquarters
- 3.6 Global Absorbable Hemostatic Agents Company, Product Type & Application
- 3.7 Global Absorbable Hemostatic Agents Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Absorbable Hemostatic Agents Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Absorbable Hemostatic Agents Players Market Share by Revenue in 2025
- 3.8.3 2025 Absorbable Hemostatic Agents Tier 1, Tier 2, and Tier 3
4 Absorbable Hemostatic Agents Regional Status and Outlook
- 4.1 Global Absorbable Hemostatic Agents Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Absorbable Hemostatic Agents Historic Market Size by Region
- 4.2.1 Global Absorbable Hemostatic Agents Sales in Volume by Region (2021-2026)
- 4.2.2 Global Absorbable Hemostatic Agents Sales in Value by Region (2021-2026)
- 4.2.3 Global Absorbable Hemostatic Agents Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Absorbable Hemostatic Agents Forecasted Market Size by Region
- 4.3.1 Global Absorbable Hemostatic Agents Sales in Volume by Region (2027-2032)
- 4.3.2 Global Absorbable Hemostatic Agents Sales in Value by Region (2027-2032)
- 4.3.3 Global Absorbable Hemostatic Agents Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Absorbable Hemostatic Agents by Application
- 5.1 Absorbable Hemostatic Agents Market by Application
- 5.1.1 Hospital
- 5.1.2 Clinics
- 5.1.3 Others
- 5.2 Global Absorbable Hemostatic Agents Market Size by Application
- 5.2.1 Global Absorbable Hemostatic Agents Market Size Overview by Application (2021-2032)
- 5.2.2 Global Absorbable Hemostatic Agents Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Absorbable Hemostatic Agents Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Absorbable Hemostatic Agents Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Absorbable Hemostatic Agents Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Absorbable Hemostatic Agents Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Absorbable Hemostatic Agents Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Absorbable Hemostatic Agents Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 BD
- 6.1.1 BD Company Information
- 6.1.2 BD Business Overview
- 6.1.3 BD Absorbable Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 BD Absorbable Hemostatic Agents Product Portfolio
- 6.1.5 BD Recent Developments
- 6.2 Biotemed
- 6.2.1 Biotemed Company Information
- 6.2.2 Biotemed Business Overview
- 6.2.3 Biotemed Absorbable Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Biotemed Absorbable Hemostatic Agents Product Portfolio
- 6.2.5 Biotemed Recent Developments
- 6.3 Cura Medical
- 6.3.1 Cura Medical Company Information
- 6.3.2 Cura Medical Business Overview
- 6.3.3 Cura Medical Absorbable Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Cura Medical Absorbable Hemostatic Agents Product Portfolio
- 6.3.5 Cura Medical Recent Developments
- 6.4 Curasan AG
- 6.4.1 Curasan AG Company Information
- 6.4.2 Curasan AG Business Overview
- 6.4.3 Curasan AG Absorbable Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Curasan AG Absorbable Hemostatic Agents Product Portfolio
- 6.4.5 Curasan AG Recent Developments
- 6.5 Foryou Medical
- 6.5.1 Foryou Medical Company Information
- 6.5.2 Foryou Medical Business Overview
- 6.5.3 Foryou Medical Absorbable Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Foryou Medical Absorbable Hemostatic Agents Product Portfolio
- 6.5.5 Foryou Medical Recent Developments
- 6.6 GELITA MEDICAL
- 6.6.1 GELITA MEDICAL Company Information
- 6.6.2 GELITA MEDICAL Business Overview
- 6.6.3 GELITA MEDICAL Absorbable Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 GELITA MEDICAL Absorbable Hemostatic Agents Product Portfolio
- 6.6.5 GELITA MEDICAL Recent Developments
- 6.7 Meril Life Sciences
- 6.7.1 Meril Life Sciences Company Information
- 6.7.2 Meril Life Sciences Business Overview
- 6.7.3 Meril Life Sciences Absorbable Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Meril Life Sciences Absorbable Hemostatic Agents Product Portfolio
- 6.7.5 Meril Life Sciences Recent Developments
- 6.8 Saikesaisi Holdings Group
- 6.8.1 Saikesaisi Holdings Group Company Information
- 6.8.2 Saikesaisi Holdings Group Business Overview
- 6.8.3 Saikesaisi Holdings Group Absorbable Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Saikesaisi Holdings Group Absorbable Hemostatic Agents Product Portfolio
- 6.8.5 Saikesaisi Holdings Group Recent Developments
- 6.9 Zhonghui Shengxi
- 6.9.1 Zhonghui Shengxi Company Information
- 6.9.2 Zhonghui Shengxi Business Overview
- 6.9.3 Zhonghui Shengxi Absorbable Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Zhonghui Shengxi Absorbable Hemostatic Agents Product Portfolio
- 6.9.5 Zhonghui Shengxi Recent Developments
- 6.10 Baxter
- 6.10.1 Baxter Company Information
- 6.10.2 Baxter Business Overview
- 6.10.3 Baxter Absorbable Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Baxter Absorbable Hemostatic Agents Product Portfolio
- 6.10.5 Baxter Recent Developments
- 6.11 Beijing Taikesiman
- 6.11.1 Beijing Taikesiman Company Information
- 6.11.2 Beijing Taikesiman Business Overview
- 6.11.3 Beijing Taikesiman Absorbable Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Beijing Taikesiman Absorbable Hemostatic Agents Product Portfolio
- 6.11.5 Beijing Taikesiman Recent Developments
- 6.12 B.Braun
- 6.12.1 B.Braun Company Information
- 6.12.2 B.Braun Business Overview
- 6.12.3 B.Braun Absorbable Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 B.Braun Absorbable Hemostatic Agents Product Portfolio
- 6.12.5 B.Braun Recent Developments
- 6.13 Beijing Datsing Bio-tech
- 6.13.1 Beijing Datsing Bio-tech Company Information
- 6.13.2 Beijing Datsing Bio-tech Business Overview
- 6.13.3 Beijing Datsing Bio-tech Absorbable Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Beijing Datsing Bio-tech Absorbable Hemostatic Agents Product Portfolio
- 6.13.5 Beijing Datsing Bio-tech Recent Developments
- 6.14 Guizhou Jin Jiu Biotech
- 6.14.1 Guizhou Jin Jiu Biotech Company Information
- 6.14.2 Guizhou Jin Jiu Biotech Business Overview
- 6.14.3 Guizhou Jin Jiu Biotech Absorbable Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Guizhou Jin Jiu Biotech Absorbable Hemostatic Agents Product Portfolio
- 6.14.5 Guizhou Jin Jiu Biotech Recent Developments
- 6.15 Johnson & Johnson
- 6.15.1 Johnson & Johnson Company Information
- 6.15.2 Johnson & Johnson Business Overview
- 6.15.3 Johnson & Johnson Absorbable Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Johnson & Johnson Absorbable Hemostatic Agents Product Portfolio
- 6.15.5 Johnson & Johnson Recent Developments
7 North America by Country
- 7.1 North America Absorbable Hemostatic Agents Sales by Country
- 7.1.1 North America Absorbable Hemostatic Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Absorbable Hemostatic Agents Sales by Country (2021-2026)
- 7.1.3 North America Absorbable Hemostatic Agents Sales Forecast by Country (2027-2032)
- 7.2 North America Absorbable Hemostatic Agents Market Size by Country
- 7.2.1 North America Absorbable Hemostatic Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Absorbable Hemostatic Agents Market Size by Country (2021-2026)
- 7.2.3 North America Absorbable Hemostatic Agents Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Absorbable Hemostatic Agents Sales by Country
- 8.1.1 Europe Absorbable Hemostatic Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Absorbable Hemostatic Agents Sales by Country (2021-2026)
- 8.1.3 Europe Absorbable Hemostatic Agents Sales Forecast by Country (2027-2032)
- 8.2 Europe Absorbable Hemostatic Agents Market Size by Country
- 8.2.1 Europe Absorbable Hemostatic Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Absorbable Hemostatic Agents Market Size by Country (2021-2026)
- 8.2.3 Europe Absorbable Hemostatic Agents Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Absorbable Hemostatic Agents Sales by Country
- 9.1.1 Asia-Pacific Absorbable Hemostatic Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Absorbable Hemostatic Agents Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Absorbable Hemostatic Agents Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Absorbable Hemostatic Agents Market Size by Country
- 9.2.1 Asia-Pacific Absorbable Hemostatic Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Absorbable Hemostatic Agents Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Absorbable Hemostatic Agents Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Absorbable Hemostatic Agents Sales by Country
- 10.1.1 South America Absorbable Hemostatic Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Absorbable Hemostatic Agents Sales by Country (2021-2026)
- 10.1.3 South America Absorbable Hemostatic Agents Sales Forecast by Country (2027-2032)
- 10.2 South America Absorbable Hemostatic Agents Market Size by Country
- 10.2.1 South America Absorbable Hemostatic Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Absorbable Hemostatic Agents Market Size by Country (2021-2026)
- 10.2.3 South America Absorbable Hemostatic Agents Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Absorbable Hemostatic Agents Sales by Country
- 11.1.1 Middle East and Africa Absorbable Hemostatic Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Absorbable Hemostatic Agents Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Absorbable Hemostatic Agents Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Absorbable Hemostatic Agents Market Size by Country
- 11.2.1 Middle East and Africa Absorbable Hemostatic Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Absorbable Hemostatic Agents Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Absorbable Hemostatic Agents Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Absorbable Hemostatic Agents Value Chain Analysis
- 12.1.1 Absorbable Hemostatic Agents Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Absorbable Hemostatic Agents Production Mode & Process
- 12.2 Absorbable Hemostatic Agents Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Absorbable Hemostatic Agents Distributors
- 12.2.3 Absorbable Hemostatic Agents Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst